Structure-Based Design and Characterization of Novel Platforms for Ricin and Shiga Toxin Inhibition

Journal of Medicinal Chemistry
2002.0

Abstract

Ribosome inhibiting proteins, RIPs, are a widespread family of toxic enzymes. Ricin is a plant toxin used as a poison and biological warfare agent; shiga toxin is a homologue expressed by pathogenic strains of E. coli. There is interest in creating effective antidote inhibitors to this class of enzymes. RIPs act by binding and hydrolyzing a specific adenine base from rRNA. Previous virtual screens revealed that pterins could bind in the specificity pocket of ricin and inhibit the enzyme. In this paper we explore a range of compounds that could serve as better platforms for inhibitor design. This establishes the importance of key hydrogen bond donors and acceptors for active-site complementarity. 8-Methyl-9-oxoguanine is a soluble compound that has the best inhibitory properties of any platform tested. The X-ray structure of this complex revealed that the inhibitor binds in an unexpected way that provides insight for future design. Several inhibitors of ricin were also shown to be inhibitors of shiga toxin, suggesting this program has the potential to develop effective antidotes to an important form of food poisoning.

Knowledge Graph

Similar Paper

Structure-Based Design and Characterization of Novel Platforms for Ricin and Shiga Toxin Inhibition
Journal of Medicinal Chemistry 2002.0
In Silico Discovery and Validation of Amide Based Small Molecule Targeting the Enzymatic Site of Shiga Toxin
Journal of Medicinal Chemistry 2016.0
Morpholino, Piperidino, and Pyrrolidino Derivatives of Pyrimidine Nucleosides as Inhibitors of Ribonuclease A: Synthesis, Biochemical, and Crystallographic Evaluation<sup>,</sup>
Journal of Medicinal Chemistry 2009.0
Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation
Bioorganic &amp; Medicinal Chemistry 2012.0
Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity
Bioorganic &amp; Medicinal Chemistry 2015.0
Structure–Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin
Journal of Medicinal Chemistry 2020.0
Identification of compounds exhibiting inhibitory activity toward the Pseudomonas tolaasii toxin tolaasin I using in silico docking calculations, NMR binding assays, and in vitro hemolytic activity assays
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Nucleoside–amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors
Bioorganic &amp; Medicinal Chemistry 2009.0
Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase
Bioorganic &amp; Medicinal Chemistry Letters 2000.0
A Virtual Screening Platform Identifies Chloroethylagelastatin A as a Potential Ribosomal Inhibitor
Biomolecules 2020.0